ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 145 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $84,728,000 | +74.8% | 4,492,466 | +9.1% | 1.58% | +90.3% |
Q2 2019 | $48,478,000 | +176.0% | 4,118,806 | +220.1% | 0.83% | -14.3% |
Q1 2019 | $17,564,000 | +52.5% | 1,286,748 | +14.5% | 0.97% | +27.6% |
Q4 2018 | $11,519,000 | -23.6% | 1,123,813 | +24.1% | 0.76% | -20.8% |
Q3 2018 | $15,072,000 | +25.7% | 905,254 | +19.3% | 0.96% | -6.5% |
Q2 2018 | $11,992,000 | +34.8% | 758,964 | +8.4% | 1.02% | +16.0% |
Q1 2018 | $8,896,000 | +2441.7% | 700,464 | +2189.1% | 0.88% | +2281.1% |
Q4 2017 | $350,000 | -13.4% | 30,600 | -7.3% | 0.04% | -11.9% |
Q3 2017 | $404,000 | +6.9% | 33,000 | 0.0% | 0.04% | -6.7% |
Q2 2017 | $378,000 | -44.9% | 33,000 | 0.0% | 0.04% | -50.5% |
Q1 2017 | $686,000 | 0.0% | 33,000 | 0.0% | 0.09% | -35.0% |
Q4 2016 | $686,000 | -36.5% | 33,000 | 0.0% | 0.14% | -28.2% |
Q3 2016 | $1,081,000 | +31.2% | 33,000 | 0.0% | 0.20% | +25.8% |
Q2 2016 | $824,000 | +2.0% | 33,000 | 0.0% | 0.16% | +5.4% |
Q1 2016 | $808,000 | – | 33,000 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |